Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3649-3653

  Husain, Syed R ^a   Behari, Niti ^a   Kreitman, Robert J ^a   Pastan, Ira ^a   Puri, Raj K ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; INTERLEUKIN 4 RECEPTOR; PROTEIN; RECOMBINANT INTERLEUKIN 4; TOXIN;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TUMOR REGRESSION; TUMOR XENOGRAFT;

ADP RIBOSE TRANSFERASES; ANIMALS; BACTERIAL TOXINS; EXOTOXINS; FEMALE; GLIOBLASTOMA; HUMANS; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INTERLEUKIN-4; MICE; RECEPTORS, INTERLEUKIN-4; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; VIRULENCE FACTORS;

EID: 0032529436     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mehaley, M. S., Jr., Mettlin, C., Natarajan, N., Laws, E. R., Jr., and Peace, B. B. National survey of patterns of care for brain tumor patients. J. Neurosurg., 71: 826-836, 1989.
2. Salcman, M. Epidemiology and factors affecting survival. In: M. L. J. Apuzzo (ed)., Malignant Cerebral Glioma. Park Ridge, IL: American Association of Neurological Surgeons, 1990, pp. 95-110.
3. Jaeckle, K. A. Immunotherapy of malignant gliomas. Semin. Oncol., 21: 249-259, 1994.
4. Pai, L. H., Wittes, R., Setser, A., Willingham, M. C., and Pastan, I. Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nat. Med., 2: 350-353, 1996.
5. Kunwar, S., Pai, L. H., and Pastan, 1. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells. J. Neurosurg., 79: 569-576, 1993.
6. Laske, D. W., Ilercil, O., Akbasak, A., Youle, R. J., and Oldfield, E. H. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. J. Neurosurg., 80: 520-526, 1994.
7. Puri, R. K., Leland, P., Kreitman, R. J., and Pastan, I. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL-4-Pseudomonas exotoxin chimeric protein. Int. J. Cancer, 58: 574-581, 1994.
8. Kreitman, R. J., Puri, R. K., and Pastan, I. A circularly permuted recombinant interleukin-4 toxin with increased activity. Proc. Natl. Acad. Sci. USA, 91: 6889-6893, 1994.
9. Kreitman, R. J., Puri, R. K., and Pastan, I. Increased antitumor activity of circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma. Cancer Res., 55: 3357-3363, 1995.
10. Puri, R. K., Leland, P., Obiri, N. I., Husain, S. R., Mule, J., Pastan, I., and Kreitman, R. J. An improved circularly permuted interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells. Cell. Immunol., 171: 80-86, 1996.
11. Puri, R. K., Hoon, D. S., Leland, P., Snoy, P., Rand, R. W., Pastan, I., and Kreitman, R. J. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma. Cancer Res., 56: 5631-5637, 1996.
12. Husain, S. R., Gill, P., Kreitman, R. J., Pastan, I., and Puri, R. K. Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin. Mol. Med., 3: 327-338, 1997.
13. 389 GRP. Cancer Res., 57: 290-294, 1997.
14. Nichols, J. Foss, F., Kuzel, T. M., LeMaistre, C. F., Platanias, L., Ratain, M. J., Rook, A., Saleh, M., and Schwartz, G. Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignancies. Eur. J. Cancer, 33: S34-S36, 1997.
15. Hall, W. A., Godal, A., Juell, S., and Fodstad, O. In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme. J. Neurosurg., 76: 838-844, 1992.
16. Yoshida, D., Piepmeier, J., and Weinstein, M. Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Res., 54: 1415-1421, 1994.
17. Husain, S. R., Obiri, N. I., Gill, P., Zheng, T., Pastan, I., Debinski, W., and Puri, R. K. Receptors for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves a new target for potent Pseudomonas exotoxin-based chimeric toxin protein. Clin. Cancer Res., 3: 151-156, 1997.
18. Debinski, W., Puri, R. K., and Pastan, I. Interleukin-4 receptors expressed on tumor cells may serve as a target for anticancer therapy using chimeric Pseudomonas exotoxin. Int. J. Cancer, 58: 744-748, 1994.
19. Morrison, P. F., Laske, D. W., Bobo, R. H., Oldfield, E. H., and Dedrick, R. L. High-flow microinfusion: tissue penetration and pharmacodynamics. Am. J. Physiol. 266: R292-R305, 1995.
20. Bobo, R. H., Laske, D. W., Akbasak, A., Morrison, P. F., Dedrick, R. L., and Oldfield, E. H. Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. USA, 91: 2076-2080, 1994.
21. Lieberman, D. M., Laske, D. W., Morrison, P. F., Bankiewicz, K. S., and Oldfield, E. H. Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J. Neurosurg., 82: 1021-1029, 1995.
22. Laske, D. W., Youle, R. J., and Oldfield, E. H. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat. Med., 3: 1362-1368, 1997.